Effect of sustained-release verapamil on the morning systemic arterial pressure surge during daily activity in patients with systemic hypertension

American Journal of Cardiology

Volumn 79, Issue 9, 1997, Pages 1252-1255

  Rosito, Guido A ^a   Gebara, Otavio C E ^a   McKenna, Carol A ^a   Solomon, Harold S ^a   Muller, James E ^a   Tofler, Geoffrey H ^a,b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VERAPAMIL;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE REGULATION; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HYPERTENSION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUSTAINED RELEASE PREPARATION;

ADULT; ANALYSIS OF VARIANCE; BLOOD PRESSURE; CIRCADIAN RHYTHM; DELAYED-ACTION PREPARATIONS; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOURIER ANALYSIS; HEART RATE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; VERAPAMIL;

EID: 0030918560     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)00093-3     Document Type: Article

References (20)

1. Tofler GH, Muller JE, Stone PH, Forman S, Solomon RE, Knatterud GL, Braunwald E. Modifiers of timing and possible triggers of acute myocardial infarction in the Thrombolysis in Myocardial Infarction Phase II (TIMI II) Study Group. J Am Coll Cardiol 1992;20:1049-1055.
2. Willich SN, Levy D, Rocco MB, Tofler GH, Stone PH, Muller JE. Circadian variation in the incidence of sudden cardiac death in the Framingham heart study population. Am J Cardiol 1987;60:801-806.
3. Millar-Craig MW, Bishop CN, Raftery EB. Circadian variation of blood pressure. Lancet 1978;1:795-797.
4. Muller JE, Abela GS, Nesto RW, Tofler GH. Triggers, acute risk factors and vulnerable plaques: the lexicon of a new frontier. J Am Coll Cardiol 1994;23:809-813.
5. Braunwald E. Morning resistance to thrombolytic therapy. Circulation 1995;91:1604-1606.
6. The Danish Study Group on Verapamil in Myocardial Infarction. Effect of verapamil on mortality and major events after acute myocardial infarction (the Danish Verapamil Infarction Trial II-DAVIT II). Am J Cardiol 1990;66:779-785.
7. Anderson LT, Sigurd BJ, Hansen JF. Verapamil and circadian variation of sudden death. Am Heart J 1996;131:409-410.
8. Gebara OCE, Jimenez AH, McKenna C, Mittleman MA, Xu P, Lipinska I, Muller JE, Tofler GH. Stress-induced hemodynamic and hemostatic changes in patients with systemic hypertension: Effect of verapamil. Clin Cardiol 1995;19:205-211.
9. Parmeggiani PL, Morrison AR. Alterations in autonomic functions during sleep. In: Lowey AD, Spyer KM (eds). Central Regulation of Autonomic Functions. New York, NY: Oxford University Press, 1990.
10. Verrier RL, Muller JE, Hobson JA. Sleep, dreams, and sudden death: the case for sleep as an autonomie stress test for the heart. Cardiovasc Res 1996;31:181-211.
11. Floras JS. Antihypertensive treatment, myocardial infarction and nocturnal myocardial ischemia. Lancet 1988;2:994-996.
12. Novo S, Alaimo G, Abrignani MG, Longo B, Muratore G, Strano A. Noninvasive blood pressure monitoring evaluation of verapamil slow-release 240 mg antihypertensive effectiveness. J Cardiovasc Pharmacol 1989;13(suppl 4):S38-S41.
13. White WB, Anders RJ, MacIntyre JM, Black HR, Sica DA. Nocturnal dosing of a novel delivery system of verapamil for systemic hypertension. Am J Cardiol 1195;76:375-380.
14. Gould B, Mann S, Kieso H, Subramanian V, Raftery E. The 24-hour ambulatory blood pressure profile with verapamil. Circulation 1982;65:22-27.
15. Sirgo A, Rose JM, De Quattro V. Effects of antihypertensive agents on circadian blood pressure and heart rate patterns. Arch Intern Med 1988;148: 2547-2552.
16. Materson BJ, Preston RA. Classic therapeutic trials in hypertension. Were patients vulnerable to unsuppressed peak morning blood pressure? Am J Hypertens 1991;4:449S-453S.
17. Woods KL, Fletcher S, Jagger C. Modification of the circadian rhythm of onset of acute myocardial infarction by long-term antianginal treatment. Br Heart J 1992;68:458-461.
18. Muller JE, Tofler GH (eds). A symposium: triggering and circadian variation of onset of acute cardiovascular disease. Am J Cardiol 1990;66:1G-70G.
19. Jimenez AH, Tofler GH, Chen X, Stubbs ME, Solomon HS, Muller JE. Effects of nadolol on hemodynamic and hemostatic responses to potential mental and physical triggers of myocardial infarction in subjects with mild systemic hypertension. Am J Cardiol 1993;72:47-52.
20. Kloner RA. Nifedipine in ischemic heart disease. Circulation 1995;92:1047-1078.